{"prompt": "['MC1752', '74', '16.', 'Bellmunt J, de Wit R, Vaughn DJ et al. AvelumabAvelumabAvelumab as Second-Line Therapy', 'for Advanced Urothelial Carcinoma. N Engl J Med 2017; 376: 1015-1026.', '17.', 'Hodge JW, Guha C, Neefjes J, Gulley JL. Synergizing radiation therapy and immunotherapy for', 'curing incurable cancers. Opportunities and challenges. Oncology (Williston Park) 2008; 22: 1064-1070;', 'discussion 1075, 1080-1061, 1084.', '18.', 'Apolo AI, J. R. et al. Avelumab (MSB0010718C; anti-PD-L1) in patients with metastatic', 'urothelial carcinoma from the JAVELIN solid tumor phase 1b trial: Analysis of safety, clinical activity,', 'and PD-L1 expression. J Clin Oncol 34, 2016 (suppl; abstr 4514).', '19.', 'Chang SS, Bochner BH, Chou R et al. Treatment of Non-Metastatic Muscle-Invasive Bladder', 'Cancer: AUA/ASCO/ASTRO/SUO Guideline. J Urol; 198: 552-559, 2017.', 'Protocol Version Date: 21JUN2018']['MC1752', '75', 'Appendix I', 'ECOG Performance Status', 'ECOG PERFORMANCE STATUS*', 'Grade', 'ECOG', '0', 'Fully active, able to carry on all pre-disease performance without restriction', '1', 'Restricted in physically strenuous activity but ambulatory and able to carry out', 'work of a light or sedentary nature, e.g., light house work, office work', '2', 'Ambulatory and capable of all selfcare but unable to carry out any work', 'activities. Up and about more than 50% of waking hours', '3', 'Capable of only limited selfcare, confined to bed or chair more than 50% of', 'waking hours.', '4', 'Completely disabled. Cannot carry on any selfcare. Totally confined to bed or', 'chair.', '5', 'Dead', '*As published in Am. J. Clin. Oncol.:', 'Oken, M.M., Creech, R.H., Tormey, D.C., Horton, J., Davis, T.E., McFadden, E.T., Carbone, P.P.:', 'Toxicity And Response Criteria Of The Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649-', '655, 1982.', 'The ECOG Performance Status is in the public domain therefore available for public use. To duplicate the', 'scale, please cite the reference above and credit the Eastern Cooperative Oncology Group, Robert Comis', 'M.D., Group Chair.', 'From http://www.ecog.org/general/perf stat.html', 'Protocol Version Date: 21JUN2018']['ENGLISH', 'Appendix II', 'EORTC QLQ-C30', 'EORTC QLQ-C30 (version 3)', 'We are interested in some things about you and your health. Please answer all of the questions yourself by circling the number that', 'best applies to you. There are no \"right\" or \"wrong\" answers. The information that you provide will remain strictly confidential.', 'Please fillin yourinitials:', 'Your birthdate (Day, Month, Year):', \"Today's date (Day, Month, Year):\", '31', 'Not at', 'A', 'Quite', 'Very', 'All', 'Little', 'a Bit', 'Much', '1. Do you have any trouble doing strenuous activities,', 'like carrying a heavy shopping bag or a suitcase?', '1', '2', '3', '4', '2. Do you have any trouble taking a longwalk?', '1', '2', '3', '4', '3.', 'Do you have any trouble taking a short walk outside of the house?', '1', '2', '3', '4', '4. Do you need to stay in bed or a chair during the day?', '1', '2', '3', '4', '5.', 'Do you need help with eating, dressing, washing', 'yourself or using the toilet?', '1', '2', '3', '4', 'Not at', 'During the past week:', 'A', 'Quite', 'Very', 'All', 'Little', 'a Bit', 'Much', '6. Were you limited in doing either your work or other daily activities?', '1', '2', '3', '4', '7.', 'Were you limited in pursuing your hobbies or other', 'leisure time activities?', '1', '2', '3', '4', '8. Were you short of breath?', '1', '2', '3', '4', '9. Have you had pain?', '1', '2', '3', '4', '10. Did you need to rest?', '1', '2', '3', '4', '11. Have you had trouble sleeping?', '1', '2', '3', '4', '12. Have you felt weak?', '1', '2', '3', '4', '13. Have you lacked appetite?', '1', '2', '3', '4', '14. Have you felt nauseated?', '1', '2', '3', '4', '15. Have you vomited?', '1', '2', '3', '4', '16. Have you been constipated?', '1', '2', '3', '4', 'Please go on to the next page', 'Protocol Version Date: 21JUN2018']\n\n###\n\n", "completion": "END"}